MILLA, Paola
MILLA, Paola
SCIENZA E TECNOLOGIA DEL FARMACO
19-azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae
1999-01-01 MILLA P; VIOLA F; CERUTI M; ROCCO F; CATTEL L; BALLIANO G
2,3-oxidosqualene cyclase from yeast: a target enzyme for drug discovery.
1996-01-01 Milla P.; Balliano G.; Ceruti M.; Cattel L.
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.
1998-01-01 M. CERUTI; F. ROCCO; F. VIOLA; G. BALLIANO; P. MILLA; S. ARPICCO; L. CATTEL
3-carboxy-4-nitrophenyl-dithio-1,1'-2-trisnorsqualene: a site directed inactivator of yeast oxidosqualene cyclase
1993-01-01 Balliano G.; Grosa G.; Milla P.; Viola F.; Cattel L.
A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al.
2014-01-01 Paola Milla; Chiara Fiorito; Francesco Soria; Silvia Arpicco; Luigi Cattel; Paolo Gontero
A Pharmacokinetics Study to Optimize Intravesical Administration of Gemcitabine
2008-01-01 Paolo Gontero; Luigi Cattel; Tonia C. Paone; Giovanna Berta; Paola Milla; Francesco Carbone; Claudio Medana; Alessandro Tizzani
A pharmacokinetics study to optimize intravesical administration of gemcitabine
2009-01-01 Paolo Gontero; Luigi Cattel; Giovanna Berta; Tonia C. Paone; Paola Milla; Claudio Medana; Francesco Carbone; Alessandro Tizzani
Active site titration of bovine beta-trypsin by N alpha-(N,N-dimethylcarbamoyl)-alpha-aza-lysine p-nitrophenyl ester: kinetic and crystallographic analysis
1995-01-01 Sartori P; Djinovic Carugo K; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
Adherence to oral chemotherapy: Evidence from a randomised clinical trial
2021-01-01 Ghiggia, Ada; Bianco, Alessandra; Castelli, Lorys; Baratta, Francesca; Birocco, Nadia; Scaldaferri, Matilde; Milla, Paola; Tesio, Valentina; Rosso, Stefano; Torta, Riccardo; Brusa, Paola; Cattel, Francesco
Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity.
2009-01-01 P. Milla; M. Airoldi; G. Weber; A. Drescher; U. Jaehde; L. Cattel
Administration of reduced glutathione in FOLFOX4 regimen in advanced colorectal cancer: effect on oxaliplatin pharmacokinetics and on Pt-DNA adducts formation
2007-01-01 M. Airoldi; P. Milla; L. Cattel; I. Gozzelino; A. Drescher; U. Jaehde; L. Branciforte; F. Pedani
Alternate scheduling of Gemcitabine (GEM) - Oxaliplatin (OXA) association in metastatic (MTS) or locally advanced (LA) pancreatic adenocarcinoma: a clinical and pharmacokinetic (pk) evaluation
2004-01-01 Airoldi M; Cattel L; Pedani F; Micari C; Nigro A; Branciforte L; Zanon C; Milla P
An independent study about over the counter medicines to analyse parents’ awareness for paediatric use
2016-01-01 Vinciguerra, V; Santarelli, F; Tempesta, E; Milla, P .
Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae
2005-01-01 Oliaro Bosso S.; Ceruti M.; Balliano G.; Milla P.; Rocco F.; Viola F.
Anti-TNF-α drugs: pharmacoeconomic analysis and proper use in pharmacological treatment in rheumatoid arthritis
2012-01-01 C. Francisco; C. Marongiu; V. Azzolini; P. Milla; V. Modena
Antibiotic adjustment in CRRT
2018-01-01 Fiorenza Ferrari, Marco Sartori, Paola Milla
Association of Gemcitabine (GEM) and Oxaliplatin (OXA) in metastatic or locally advanced pancreatic adenocarcinoma: a clinical and pharmacokinetic (PK) study
2004-01-01 Airoldi M; Cattel L; Passera R; Micari C; Nigro A; Milla P
Chemical and microbiological stability, anticoagulant efficacy and toxicity of 35 and 90 mM trisodium citrate solutions stored in plastic syringes
2018-01-01 Milla, Paola; Viterbo, Maria Luisa; Mosca, Sabino; Arpicco, Silvia
Clinical Assessment of Continuous Hemodialysis with the Medium Cutoff EMiC ® 2 Membrane in Patients with Septic Shock
2022-01-01 Ferrari F.; Husain-Syed F.; Milla P.; Lorenzin A.; Scudeller L.; Sartori M.; Gramaticopolo S.; D'Auria L.; Guglielmi A.; Cornara P.; De Rosa S.; Zanella M.; Corradi V.; De Cal M.; Danzi V.; Giavarina D.; Brendolan A.; Mojoli F.; Arpicco S.; Ronco C.
Coagulation Factor VIII: pharmacoeconomic evaluation and quality of life as measuring tools in clinical practice
2012-01-01 F. Donato; M. Ferroni; M. Messina; P. Schinco; M. Marengo; A. Elia; F. Cattel; P. Milla; M. Miglietta; L. Cattel